Literature DB >> 6528366

[DNA synthesis in the nuclei of resting and proliferating cells of the NIH 3T3 line in monokaryons, homo- and heterodikaryons].

N A Setkov, V A Polunovskiĭ, O I Epifanova.   

Abstract

Serum-deprived (0.5%) resting NIH 3T3 mouse fibroblasts were fused with stimulated cells taken at 2 hour intervals after changing the medium to the one containing 10% serum, and DNA synthesis was investigated in monokaryons, homodikaryons, and heterodikaryous using radioautography with double-labeling technique. The presence of the resting nucleus in the common cytoplasm has an inhibitory effect on the entry of the stimulated nucleus into the S period in the medium containing either 0.5 or 10% serum, but DNA synthesis continues. After a 24 hour stay in the common cytoplasm with resting nuclei the stimulated nuclei return into the state of rest. When resting cells are stimulated by 10% serum, their inhibitory effect on stimulated nuclei in heterodikaryons still persists for at least 2 hours following stimulation. Preincubation of resting cells with cycloheximide for 4 hours abolishes their ability to suppress DNA synthesis in stimulated nuclei. The data suggest that the resting cells produce an endogenous inhibitor of cell proliferation whose formation depends upon the synthesis of protein(s). When stimulated, cell can proliferate only upon decreasing the level of this inhibitor. The obtained results are consistent with the idea of a negative control of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6528366

Source DB:  PubMed          Journal:  Tsitologiia        ISSN: 0041-3771


  2 in total

1.  The mechanisms of endogenous control of hepatocyte proliferation are different in mice of two inbred strains (BALB/c and AKR).

Authors:  A V Eremeev; O A Timofeeva; V I Kaledin; N A Setkov
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

Review 2.  TNF in the era of immune checkpoint inhibitors: friend or foe?

Authors:  Allen Y Chen; Jedd D Wolchok; Anne R Bass
Journal:  Nat Rev Rheumatol       Date:  2021-03-08       Impact factor: 20.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.